Pituitary apoplexy medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 18: | Line 18: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 16:26, 18 October 2017
|
Pituitary apoplexy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pituitary apoplexy medical therapy On the Web |
|
American Roentgen Ray Society Images of Pituitary apoplexy medical therapy |
|
Risk calculators and risk factors for Pituitary apoplexy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
The optimal therapy for pituitary apoplexy depends upon the presentationn of the patient. The emphasis is on early hemodynamic stabilization of the patient, with evaluation for signs of pituitary hormones deficiency. Life threatening hypopituitarism must be treated with replacement of hormones.
Medical Therapy
Medical treatment consists of:[1][2][3]
- Hemodynamic stabilization of the patient with evaluation for signs of pituitary hormones deficiency and electrolyte abnormalities.
- Most patients have life threatening hypopituitarism. Replace hormones with:
- High-dose corticosteroids
- Sex hormones (estrogen/testosterone)
- Thyroid hormone
- Evidence is also growing for the need to replace growth hormone.
References
- ↑ Veldhuis JD, Hammond JM (1980). "Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal". Endocr. Rev. 1 (1): 100–7. doi:10.1210/edrv-1-1-100. PMID 6785084.
- ↑ Oelkers W (1996). "Adrenal insufficiency". N. Engl. J. Med. 335 (16): 1206–12. doi:10.1056/NEJM199610173351607. PMID 8815944.
- ↑ De Ycaza AE, Chang AY, Jensen JR, Khan Z, Erickson D (2015). "Approach to the management of rare clinical presentations of macroprolactinomas in reproductive-aged women". Case Rep Womens Health. 8: 9–12. doi:10.1016/j.crwh.2015.09.001. PMC 5033506. PMID 27668187.